Related Experiment Videos
A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
M A Garvey1, S J Perlmutter, A J Allen
1Pediatrics and Developmental Neuropsychiatry Branch, National Institutes of Mental Health, Bethesda, MD, USA.
Insights
Penicillin prophylaxis did not prevent symptom exacerbations in children with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS). Further research with more effective prophylaxis is needed to confirm penicillin
Area of Science:
- Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS)
- Neuropsychiatric disorders
- Streptococcal infections
Background:
- Some children experience worsening OCD and tic disorders due to streptococcal infections.
- This is similar to Sydenham's chorea, a neurologic variant of rheumatic fever.
- Penicillin prophylaxis prevents rheumatic fever recurrences, suggesting potential benefit for PANDAS.
Purpose of the Study:
- To investigate if penicillin prophylaxis can prevent symptom exacerbations in children with PANDAS.
- To assess the efficacy of penicillin in managing PANDAS symptoms.
Main Methods:
- An 8-month, double-blind, cross-over study involving 37 children with PANDAS.
- Patients received either penicillin V or placebo for 4 months each.
- Symptoms, throat cultures, and antibody titers were monitored monthly.
Main Results:
- No significant difference in infection rates between penicillin and placebo phases.
- No significant change in obsessive-compulsive or tic symptom severity was observed between phases.
Conclusions:
- The study could not conclude on penicillin's efficacy due to inadequate streptococcal prophylaxis.
- Future studies require more effective prophylactic agents and larger sample sizes.
- Further research is needed to confirm or refute penicillin's role in PANDAS management.
Background:
Some children with obsessive-compulsive disorder (OCD) and tic disorders appear to have symptom exacerbations triggered by group A beta-hemolytic streptococcal infections in a manner that is similar to rheumatic fever and its neurologic variant, Sydenham's chorea. Because penicillin prophylaxis has proven to be effective in preventing recurrences of rheumatic fever, it was postulated that it might also prevent streptococcal-triggered neuropsychiatric symptom exacerbations in children with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS). These children are identified by five clinical characteristics: presence of OCD or tic disorder, prepubertal onset, episodic symptom course, neurologic abnormalities (i.e., choreiform movements) and streptococcal-triggered symptom exacerbations.
Methods:
Thirty-seven children with PANDAS were enrolled in an 8 month, double-blind, balanced cross-over study. Patients were randomized to receive either 4 months of the active compound (twice daily oral 250 mg penicillin V) followed by 4 months of placebo, or placebo followed by penicillin V. Tic, OCD, and other psychiatric symptoms were monitored monthly. Throat cultures and streptococcal antibody titers were also obtained.
Results:
There were an equal number of infections in both the active and placebo phases of the study. There was no significant change seen in either the obsessive-compulsive or tic symptom severity between the two phases.
Conclusions:
Because of the failure to achieve an acceptable level of streptococcal prophylaxis, no conclusions can be drawn from this study regarding the efficacy of penicillin prophylaxis in preventing tic or OCD symptom exacerbations. Future studies should employ a more effective prophylactic agent, and include a larger sample size.